Donor Screening & Recovery
Following rigorous guidelines and procedures
RevoGen Biologics and our strategic partners go to great lengths when screening, recovering, processing, storing and distributing donor tissue. It is our common goal to treat each donor and their families with the utmost respect and to maximize the benefit for our allograft tissue recipients.
When screening donors and recovering tissue, the highest standards must be upheld. Each prospective donor is put through a comprehensive screening process, including medical and social history evaluations that are in accordance with Food and Drug Administration (FDA) regulations and American Association of Tissue Banks (AATB) standards.
Upon receiving consent from the donor’s family, qualified personnel perform and document a physical examination of the prospective donor.Following the physical examination, a full review of the donor’s medical records is then performed. Finally, if the perspective donor is approved, the donor tissue is then tested by a CLIA certified, FDA registered laboratory. These tests include, but are not limited to Anti-HBc, Anti-HCV, Anti-HIV Type 1 and 2, HBsAg, HIV-1 and HCV (NAT) and Syphilis.
RevoGen Biologics and our strategic partners is committed to follow rigorous guidelines and procedures to ensure only uniform, high-quality donor tissue is recovered and processed for distribution.
The allograft tissue recovery process begins after a prospective donor has passed our stringent screening process. Highly trained technicians operate in state-of-the-art designated clean rooms to process and prepare donor tissue.